NCT06277479View on ClinicalTrials.gov

Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional Study

CompletedOBSERVATIONAL
Enrollment

1,262

Participants

Timeline

Start Date

May 25, 2024

Primary Completion Date

August 1, 2024

Study Completion Date

August 1, 2024

Conditions
Hematological Diseases
Trial Locations (1)

2100

Mette Schaufuss Engedal, Copenhagen

All Listed Sponsors
collaborator

Danish Cancer Society

OTHER

lead

Rigshospitalet, Denmark

OTHER

NCT06277479 - Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional Study | Biotech Hunter | Biotech Hunter